Organ-on-a-chip is a micro-fluidic cell-culture appliance, generally developed using the microchip manufacturing methods that include constantly perfused chambers inhabited by the living cells arranged to reproduce tissue and organ-level physiology. The chip develops a slight channel for blood & air flow in different organs like gut, liver, lung, heart, and others. Such devices generate several levels of tissue and organ functionalities that cannot be achieved with conventional 2D and 3D culture systems. Organ-on-chip provides an extensive range of applications for instance patient stratification, diseases modeling, and phenotypic screening.
As per analysis, Global Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Region: Trend Forecast and Growth Opportunity. Some of the key companies operating in the global organ-on-chip market include CN Bio Innovations, Ltd., AxoSim Inc., Kirkstall, Ltd., Cherry Biotech, Emulate Inc., BiomimX SRL, Nortis Inc., Kirkstall, Ltd., Tara Biosystems Inc., MIMETAS BV, SynVivo, Inc, TissUse GmbH, InSphero AG, Tara Biosystems Inc., Hurel Corporation and among others.
Based on offering, organ-on-chip market can be segregated as servicGlobal Organ-on-Chip Market, Global Organ-on-Chip Industryes and chips. Based on organ type, market can be segregated as Heart-on-a-Chip, Brain-on-a-Chip, Liver-on-a-Chip, Kidney-on-a-Chip, Skin-on-a-Chip, Lung-on-a-Chip, Vessels-on-a-Chip and other organ types. Based on materials, market can be segregated as glass, polymers and silicon. Based on application, market can be segregated as toxicology research, drug discovery and others. In addition, based on end-user, market can be segregated as cosmetic industry, academic & research institutes and pharmaceutical & biotechnology companies.
Growth in technological advancements & new products launches, followed by increase in need for early detection of drug toxicity to minimize financial losses, significant increase in the research funding & venture capital investments for development of organs-on-chips, rise in need for early drug detection, increase in number of partnerships & collaborations between pharmaceutical companies, growth in focus on developing alternatives for animal testing models, increase in focus on developing alternatives for animal testing models and growth in initiatives to increase the awareness about organs-on-chips technologies are some major factors, which are responsible for growth of the organ-on-chip market. Apart from this, complexity of organs-on-chips models and increase in issues related to incorporation of the organs-on-chips technologies into existing workflows may impact the market. Moreover, growth in development of multiple-organs-on-a-chip models and increase in application of organs-on-chips in oncology research are leading opportunities for market.
Based on regional analysis, the North-America is a leading region in global organ-on-chip market owing to growth in healthcare applications, increase in toxicological testing of chemicals on the different types of organ cells and growth in innovation in advanced technologies across the region. The Europe and Asia-Pacific regions are projected to witness higher growth rate due to increase in need for early detection of drug toxicity and new products launches over the forecast period. It is estimated that future of the global organ-on-chip market will be bright as a result of increase in instances of cardiovascular diseases (CVD) and growth in requirement of alternative for animal testing during the forecast period.
For More Information, click on the link below:-
North America Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity
Ankur Gupta, Head Marketing & Communications